ClinicalTrials.Veeva

Menu
N

Nippon Medical School Chiba Hokusoh Hospital | Clinical Trial Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Venlafaxine
Apixaban
Sacituzumab
Muvalaplin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials
New

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) (MOVE-Lp(a))

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Placebo
Drug: Muvalaplin

The goal of this clinical study is to compare the study drug, sacituzumab govitecan-hziy (SG), versus docetaxel in participants with advanced or meta...

Active, not recruiting
Non-Small Cell Lung Cancer
Biological: Sacituzumab Govitecan-hziy (SG)
Drug: Docetaxel

Trial sponsors

Chugai Pharmaceutical logo
Viatris logo
Bayer logo
Gilead Sciences logo
Lilly logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems